Results 161 to 170 of about 2,641,102 (341)
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Farkhad Manapov,1,2 Lukas Käsmann,1 Olarn Roengvoraphoj,1 Maurice Dantes,1 Nina-Sophie Schmidt-Hegemann,1 Claus Belka,1,2 Chukwuka Eze1 1Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; 2Comprehensive Pneumology ...
Manapov F +6 more
doaj
Immunohistochemical Characterization of Three Monoclonal Antibodies Raised against the Epidermal Growth Factor and Its Receptor in Non-Small-Cell Lung Cancer: Their Potential Use in the Selection of Patients for Immunotherapy [PDF]
Charles E. Rengifo +5 more
openalex +1 more source
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source
Factors Influence the Selection of Myopia Management Modality for Myopic Patients
Mohd Zaki Awg Isa +1 more
openalex +2 more sources
Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma [PDF]
Hans‐Christian Pommergaard
openalex +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Which patients should be treated with anti-IgE?
In the European Union, omalizumab is indicated as add-on therapy to improve asthma control in adult and adolescent patients (12 yrs of age) with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial ...
K-M. Beeh
doaj
P07 The use of a CTCA based virtual stent planner in patient selection for percutaneous coronary intervention [PDF]
David Murphy +11 more
openalex +1 more source

